SCHEMBL8588624

SCHEMBL8588624

CCOCC(C)CCOC(C)=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.55
▸ TSHR P16473 2/20 0.55
▸ ALOX15 P16050 1/20 0.51
▸ HSD17B10 Q99714 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ CHRNB2 P17787 4/20 0.36
▸ CHRNA4 P43681 4/20 0.36
▸ CHRNB4 P30926 3/20 0.36
▸ CHRNA3 P32297 3/20 0.36
▸ CHRM5 P08912 2/20 0.36
▸ CHRM1 P11229 2/20 0.36
▸ CHRM3 P20309 2/20 0.36
▸ PGR P06401 1/20 0.36
▸ CHRM2 P08172 1/20 0.36
▸ CHRM4 P08173 1/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ TBXA2R P21731 1/20 0.36
▸ CHRNA7 P36544 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ CHRNA10 Q9GZZ6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11619041 0.84 ALOX15 (0.58) ALDH1A1TSHRALOX15HSD17B10LMNA
SCHEMBL14438593 0.82 ALDH1A1 (0.50) ALDH1A1TSHRALOX15HSD17B10LMNA
SCHEMBL3784335 0.82 ALOX15 (0.56) ALDH1A1TSHRALOX15HSD17B10LMNA
SCHEMBL7552905 0.81 ALOX15 (0.70) ALDH1A1TSHRALOX15HSD17B10LMNA
SCHEMBL4840226 0.79 ALOX15 (0.58) ALDH1A1TSHRALOX15HSD17B10LMNA
SCHEMBL6002350 0.79 ALDH1A1 (0.53) ALDH1A1TSHRALOX15HSD17B10LMNA
SCHEMBL15542057 0.78 ALOX15 (0.61) ALDH1A1TSHRALOX15HSD17B10LMNA
SCHEMBL21598310 0.77 ALDH1A1 (0.38) ALDH1A1TSHRHSD17B10TDP1
SCHEMBL21598304 0.77 ALDH1A1 (0.38) ALDH1A1TSHRHSD17B10TDP1
SCHEMBL25341103 0.76 ALOX15 (0.59) ALDH1A1TSHRALOX15HSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4334397-A1 METHOD FOR THE MANUFACTURE OF PANELS; AND PANELS OBTAINED THEREBY Flooring Industries Limited, SARL (LU) 2024-03-13 — — EP claimed
EP-4334397-A1 METHOD FOR THE MANUFACTURE OF PANELS; AND PANELS OBTAINED THEREBY Flooring Industries Limited, SARL (LU) 2024-03-13 — — EP disclosed
WO-2023170577-A1 USE OF A HYDROPHOBIC POLYMER ON DECORATIVE PANELS AND METHOD FLOORING INDUSTRIES LIMITED, SARL (LU) 2023-09-14 — — WO disclosed
WO-2021116792-A1 FLOOR ELEMENT AND METHOD FOR MANUFACTURING FLOOR ELEMENTS FLOORING INDUSTRIES LIMITED, SARL (LU) 2021-06-17 — — WO disclosed
US-20070179100-A1 Protected monomers ALNYLAM PHARMACEUTICALS, INC. 2007-08-02 — — US disclosed
US-5756260-A POLYAMIC ACID ESTER, PROPYLENE GLYCOL MONOMETHYL ETHER ACETATE SUMITOMO BAKELITE COMPANY LIMITED (JP) 1998-05-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179100-A1 Protected monomers PCNA, POLN, PARP1 ALDH1A1 1923/4885TSHR 4147/4885ALOX15 3165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback